{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:44:46Z","timestamp":1793432686667,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3OT2OD023848"],"award-info":[{"award-number":["3OT2OD023848"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 HL144980"],"award-info":[{"award-number":["R35 HL144980"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA068485"],"award-info":[{"award-number":["P30CA068485"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["S10 OD023475-01A1"],"award-info":[{"award-number":["S10 OD023475-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19SFRN34830019"],"award-info":[{"award-number":["19SFRN34830019"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.yjmcc.2023.05.009","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T19:01:02Z","timestamp":1685991662000},"page":"67-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease"],"prefix":"10.1016","volume":"181","author":[{"given":"Jeffrey","family":"Schmeckpeper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn A.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor R.","family":"Efimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn C.","family":"Knollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.yjmcc.2023.05.009_bb0005","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.05.009_bb0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial","volume":"324","author":"Echt","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.05.009_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction","volume":"327","author":"Cardiac Arrhythmia Suppression Trial III","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2023.05.009_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-physiol-020911-153308","article-title":"Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction","volume":"76","author":"Bers","year":"2014","journal-title":"Annu. Rev. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.05.009_bb0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10741-012-9339-6","article-title":"The ryanodine receptor leak: how a tattered receptor plunges the failing heart into crisis","volume":"18","author":"Fischer","year":"2013","journal-title":"Heart Fail. Rev."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.05.009_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1073\/pnas.0510113103","article-title":"Ryanodine receptor\/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression","volume":"103","author":"Wehrens","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.05.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.114.300568","article-title":"Role of RyR2 phosphorylation in heart failure and arrhythmias: controversies around ryanodine receptor phosphorylation in cardiac disease","volume":"114","author":"Dobrev","year":"2014","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.05.009_bb0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.RES.0000159387.00749.3c","article-title":"Cellular mechanism of calcium-mediated triggered activity in the heart","volume":"96","author":"Katra","year":"2005","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.05.009_bb0045","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41569-020-00443-x","article-title":"Mechanisms of ryanodine receptor 2 dysfunction in heart failure","volume":"17","author":"Alvarado","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.05.009_bb0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.yjmcc.2008.12.005","article-title":"What role does modulation of the ryanodine receptor play in cardiac inotropy and arrhythmogenesis?","volume":"46","author":"Eisner","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.05.009_bb0055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.110.238386","article-title":"Small-conductance calcium-activated potassium channel and recurrent ventricular fibrillation in failing rabbit ventricles","volume":"108","author":"Chua","year":"2011","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.009_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2019.10.071","article-title":"Dantrolene prevents ventricular tachycardia by stabilizing the ryanodine receptor in pressure- overload induced failing hearts","volume":"521","author":"Kajii","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"25","key":"10.1016\/j.yjmcc.2023.05.009_bb0065","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","article-title":"Left ventricular remodeling after myocardial infarction: pathophysiology and therapy","volume":"101","author":"Sutton","year":"2000","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.05.009_bb0070","doi-asserted-by":"crossref","first-page":"H953","DOI":"10.1152\/ajpheart.00936.2011","article-title":"Dantrolene prevents arrhythmogenic Ca2+ release in heart failure","volume":"302","author":"Maxwell","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.05.009_bb0075","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1172\/JCI32726","article-title":"Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice","volume":"120","author":"Shan","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.05.009_bb0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.hroo.2020.03.004","article-title":"Chronic dantrolene treatment attenuates cardiac dysfunction and reduces atrial fibrillation inducibility in a rat myocardial infarction heart failure model","volume":"1","author":"Nofi","year":"2020","journal-title":"Heart Rhythm O2."},{"key":"10.1016\/j.yjmcc.2023.05.009_bb0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijcard.2016.10.021","article-title":"Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated ca(2+) release","volume":"225","author":"Reynolds","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.05.009_bb0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/jce.12320","article-title":"Dantrolene suppresses ventricular ectopy and arrhythmogenicity with acute myocardial infarction in a langendorff-perfused pacing-induced heart failure rabbit model","volume":"25","author":"Chou","year":"2014","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.009_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pbiomolbio.2010.01.002","article-title":"Cardiomyocytes hypertrophic status after myocardial infarction determines distinct types of arrhythmia: role of the ryanodine receptor","volume":"103","author":"Fauconnier","year":"2010","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.05.009_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1388-9842(99)00017-3","article-title":"Dantrolene sodium improves the force-frequency relationship and beta-adregenic responsiveness in failing human myocardium","volume":"1","author":"Meissner","year":"1999","journal-title":"Eur. J. Heart Fail."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.05.009_bb0105","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.113.006611","article-title":"Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model","volume":"129","author":"Li","year":"2014","journal-title":"Circulation."},{"issue":"21","key":"10.1016\/j.yjmcc.2023.05.009_bb0110","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2009.01.065","article-title":"Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor","volume":"53","author":"Kobayashi","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.05.009_bb0115","article-title":"Altered calcium handling produces reentry-promoting action potential alternans in atrial fibrillation-remodeled hearts. JCI","volume":"5","author":"Liu","year":"2020","journal-title":"Insight."},{"key":"10.1016\/j.yjmcc.2023.05.009_bb0120","article-title":"Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice","volume":"2(6Part B):733-41","author":"Azam","year":"2021","journal-title":"Heart Rhythm O2."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.05.009_bb0125","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.113.005443","article-title":"Dantrolene improves survival after ventricular fibrillation by mitigating impaired calcium handling in animal models","volume":"129","author":"Zamiri","year":"2014","journal-title":"Circulation."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.05.009_bb0130","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.109.209312","article-title":"Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor","volume":"106","author":"Uchinoumi","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.05.009_bb0135","article-title":"Permanent ligation of the left anterior descending coronary artery in mice: a model of post-myocardial infarction remodelling and heart failure","volume":"94","author":"Muthuramu","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.05.009_bb0140","doi-asserted-by":"crossref","first-page":"H753","DOI":"10.1152\/ajpheart.00404.2012","article-title":"Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes","volume":"303","author":"Laughner","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.05.009_bb0145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.107.157552","article-title":"Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice","volume":"101","author":"Chopra","year":"2007","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.05.009_bb0150","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1073\/pnas.1816685116","article-title":"Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic","volume":"116","author":"Batiste","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.yjmcc.2023.05.009_bb0155","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/cvr\/cvx151","article-title":"Hierarchical statistical techniques are necessary to draw reliable conclusions from analysis of isolated cardiomyocyte studies","volume":"113","author":"Sikkel","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"25","key":"10.1016\/j.yjmcc.2023.05.009_bb0160","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","article-title":"Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both","volume":"352","author":"Solomon","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.05.009_bb0165","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1540-8167.2003.03228.x","article-title":"Mechanisms of clinical arrhythmias","volume":"14","author":"Zipes","year":"2003","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.05.009_bb0170","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.hrthm.2015.06.019","article-title":"Delayed afterdepolarizations generate both triggers and a vulnerable substrate promoting reentry in cardiac tissue","volume":"12","author":"Liu","year":"2015","journal-title":"Heart Rhythm."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.05.009_bb0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM199401273300402","article-title":"Electrical alternans and vulnerability to ventricular arrhythmias","volume":"330","author":"Rosenbaum","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.yjmcc.2023.05.009_bb0180","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.107.748962","article-title":"Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy","volume":"118","author":"Gold","year":"2008","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.05.009_bb0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1152\/physrev.00011.2006","article-title":"Calcium and arrhythmogenesis","volume":"87","author":"Ter Keurs","year":"2007","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.05.009_bb0190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000240542.03986.e7","article-title":"Spatially discordant alternans in cardiac tissue: role of calcium cycling","volume":"99","author":"Sato","year":"2006","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.05.009_bb0195","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.yjmcc.2010.11.019","article-title":"Alternans of action potential duration and amplitude in rabbits with left ventricular dysfunction following myocardial infarction","volume":"50","author":"Myles","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.05.009_bb0200","series-title":"Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference","first-page":"4527","article-title":"Enhanced susceptibility to alternans in a rabbit model of chronic myocardial infarction","volume":"2009","author":"Lou","year":"2009"},{"issue":"12","key":"10.1016\/j.yjmcc.2023.05.009_bb0205","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.CIR.99.12.1637","article-title":"Intracoronary flecainide induces ST alternans and reentrant arrhythmia on intact canine heart: a role of 4-aminopyridine-sensitive current","volume":"99","author":"Tachibana","year":"1999","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.05.009_bb0210","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/01.CIR.92.5.1300","article-title":"Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs","volume":"92","author":"Ranger","year":"1995","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.009_bb0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.CIR.91.1.245","article-title":"The cardiac arrhythmia suppression trial. Casting suppression in a different light","volume":"91","author":"Pratt","year":"1995","journal-title":"Circulation."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.05.009_bb0220","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.05.009_bb0225","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/CIRCRESAHA.111.300290","article-title":"In cardiomyocytes, binding of unzipping peptide activates ryanodine receptor 2 and reciprocally inhibits calmodulin binding","volume":"112","author":"Oda","year":"2013","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.05.009_bb0230","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hrthm.2016.09.014","article-title":"Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes","volume":"14","author":"Hartmann","year":"2017","journal-title":"Heart Rhythm."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.05.009_bb0235","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.118.034609","article-title":"Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure","volume":"138","author":"Valiente-Alandi","year":"2018","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.05.009_bb0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCRESAHA.113.301152","article-title":"Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction","volume":"113","author":"Konstandin","year":"2013","journal-title":"Circ. Res."},{"issue":"23","key":"10.1016\/j.yjmcc.2023.05.009_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24234298","article-title":"A prospective repurposing of Dantrolene as a multitarget agent for Alzheimer\u2019s disease","volume":"24","author":"Bolognino","year":"2019","journal-title":"Molecules."},{"issue":"21","key":"10.1016\/j.yjmcc.2023.05.009_bb0250","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1161\/CIRCULATIONAHA.104.528133","article-title":"Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury","volume":"112","author":"Bianchi","year":"2005","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.009_bb0255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCRESAHA.109.198366","article-title":"Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload","volume":"106","author":"Kaludercic","year":"2010","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.05.009_bb0260","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1096\/fj.15-277046","article-title":"Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions","volume":"30","author":"Roy","year":"2016","journal-title":"FASEB J."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:38:21Z","timestamp":1758314301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282823001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":52,"alternative-id":["S0022282823001013"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.05.009","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}